Mocarski E S, Bonyhadi M, Salimi S, McCune J M, Kaneshima H
Department of Microbiology and Immunology, Stanford University School of Medicine, CA 94305-5402.
Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):104-8. doi: 10.1073/pnas.90.1.104.
Animal models of human cytomegalovirus (CMV) infections have not been available to study pathogenesis or to evaluate antiviral drugs. Severe combined immunodeficient mice implanted with human fetal tissues (SCID-hu) were found to support CMV replication and may provide a model for this species-specific virus. When conjoint implants of human fetal thymus and liver were inoculated with a low-passage-number isolate of CMV, strain Toledo, consistent high-level viral replication was detected 5, 12, 15, 28, and 35 days after inoculation and virus replication continued for up to 9 months. Other human tissue implants, including lung and colon, were also found to support viral growth but with greater variability in levels and for a shorter duration. As expected, the species specificity of human CMV was preserved in this model such that virus was detected in the human conjoint thymus/liver implant but not in surrounding mouse tissues. The majority of virus-infected cells were localized in the thymic medulla rather than cortical region of the implant and immunofluorescence analysis identified epithelial cells rather than any hematopoietic cell population as the principal hosts for viral replication. Finally, treatment of infected animals with ganciclovir reduced viral replication, thereby demonstrating the value of this system for evaluating antiviral therapies. This animal model opens the way for a range of investigations not previously possible with human CMV.
此前一直没有可用于研究人类巨细胞病毒(CMV)感染发病机制或评估抗病毒药物的动物模型。研究发现,植入人胎儿组织的严重联合免疫缺陷小鼠(SCID-hu)能够支持CMV复制,可能为这种具有物种特异性的病毒提供一个模型。用人胎儿胸腺和肝脏的联合植入物接种低传代分离株CMV Toledo株后,在接种后5、12、15、28和35天检测到持续的高水平病毒复制,病毒复制持续长达9个月。还发现其他人体组织植入物,包括肺和结肠,也能支持病毒生长,但水平变化较大且持续时间较短。正如预期的那样,人CMV的物种特异性在该模型中得以保留,即在人胸腺/肝脏联合植入物中检测到病毒,而在周围的小鼠组织中未检测到。大多数病毒感染细胞位于植入物的胸腺髓质而非皮质区域,免疫荧光分析确定上皮细胞而非任何造血细胞群体是病毒复制的主要宿主。最后,用更昔洛韦治疗感染动物可减少病毒复制,从而证明该系统在评估抗病毒治疗方面的价值。这种动物模型为一系列以前无法用人CMV进行的研究开辟了道路。